Venture capital firm Index Ventures has made its biggest investment yet in a life sciences firm after putting $11m behind biotech firm XO1 from its $200m life sciences fund backed by drugs companies Johnson & Johnson and GlaxoSmithKline (GSK).
Index, which has 21 current life science investments in its portfolio, was the sole participant in the seed round for XO1. Kevin Johnson, partner at Index Ventures, said: “This represents the largest investment in a life science company by Index Ventures…
The University of Kentucky has formed an industry-university partnership to advance aspects such as sustainable agriculture in the whiskey distilling industry.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
